全文获取类型
收费全文 | 88933篇 |
免费 | 8791篇 |
国内免费 | 179篇 |
专业分类
耳鼻咽喉 | 1228篇 |
儿科学 | 2673篇 |
妇产科学 | 1996篇 |
基础医学 | 12797篇 |
口腔科学 | 2151篇 |
临床医学 | 10801篇 |
内科学 | 15875篇 |
皮肤病学 | 1464篇 |
神经病学 | 7528篇 |
特种医学 | 2910篇 |
外国民族医学 | 10篇 |
外科学 | 12023篇 |
综合类 | 1677篇 |
一般理论 | 70篇 |
预防医学 | 10009篇 |
眼科学 | 1973篇 |
药学 | 7196篇 |
1篇 | |
中国医学 | 103篇 |
肿瘤学 | 5418篇 |
出版年
2021年 | 1310篇 |
2020年 | 857篇 |
2019年 | 1314篇 |
2018年 | 1596篇 |
2017年 | 1191篇 |
2016年 | 1301篇 |
2015年 | 1447篇 |
2014年 | 1876篇 |
2013年 | 2910篇 |
2012年 | 4014篇 |
2011年 | 4317篇 |
2010年 | 2271篇 |
2009年 | 2176篇 |
2008年 | 3637篇 |
2007年 | 3963篇 |
2006年 | 3802篇 |
2005年 | 3878篇 |
2004年 | 3591篇 |
2003年 | 3346篇 |
2002年 | 3267篇 |
2001年 | 2785篇 |
2000年 | 2887篇 |
1999年 | 2580篇 |
1998年 | 1101篇 |
1997年 | 914篇 |
1996年 | 890篇 |
1995年 | 794篇 |
1994年 | 828篇 |
1993年 | 751篇 |
1992年 | 2124篇 |
1991年 | 2058篇 |
1990年 | 1926篇 |
1989年 | 1872篇 |
1988年 | 1784篇 |
1987年 | 1792篇 |
1986年 | 1694篇 |
1985年 | 1673篇 |
1984年 | 1405篇 |
1983年 | 1264篇 |
1982年 | 844篇 |
1981年 | 724篇 |
1979年 | 1221篇 |
1978年 | 877篇 |
1977年 | 764篇 |
1976年 | 718篇 |
1975年 | 716篇 |
1974年 | 864篇 |
1973年 | 757篇 |
1972年 | 737篇 |
1971年 | 640篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
2.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
3.
4.
5.
James Milligan Joseph Lee Matt Smith Lindsay Donaldson Peter Athanasopoulos Kent Bassett-Spiers 《The journal of spinal cord medicine》2020,43(2):223-233
Context: Persons with spinal cord injury (SCI) experience significant challenges when they access primary care and community services.Design: A provincial summit was held to direct research, education, and innovation for primary and community care for SCI.Setting: Toronto, Ontario, Canada.Participants: Key stakeholders (N?=?95) including persons with SCI and caregivers, clinicians from primary care, rehabilitation, and specialized care, researchers, advocacy groups, and policy makers.Methods: A one-day facilitated meeting that included guest speakers, panel discussions and small group discussions was held to generate potential solutions to current issues related to SCI care and to foster collaborative relationships to advance care for SCI. Perspectives on SCI management were shared by primary care, neurosurgery, rehabilitation, and members of the SCI communityOutcome Measures: Discussions were focused on five domains: knowledge translation and dissemination, application of best practices, communication, research, and patient service accessibility.Results: Summit participants identified issues and prioritized solutions to improve primary and community care including the creation of a network of key stakeholders to enable knowledge creation and dissemination; an online repository of SCI resources, integrated health records, and a clinical network for SCI care; development and implementation of strategies to improve care transitions across sectors; implementation of effective care models and improved access to services; and utilization of empowerment frameworks to support self-management.Conclusions: This summit identified priorities for further collaborative efforts to advance SCI primary and community care and will inform the development of a provincial SCI strategy aimed at improving the system of care for SCI. 相似文献
6.
7.
8.
In 1963, Goffman argued that forming a group based on shared stigma may provide benefits. However, there is no empirical research on whether perception that a separate, unique, coherent group exists (i.e., group entitativity) influences coping, such as educating others or secrecy, for the stigmatized individual or his or her spouse. Further, little is known about how spouses influence each other in terms of promoting the education of others about a stigmatizing condition, especially when it comes to the role of believing that stigma-based groups, to which they may both belong, exist. This study provides a step toward bridging this gap in the research by applying the label management model in efforts to understand coping for couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). This study included 50 married couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). We found that group entitativity related to those with AATD counterbalanced the influence of genetic stigma on spouses’ intentions to keep the diagnosis secret or to educate others about it. Intrapersonal and interpersonal influences appeared among spouses. Attention is needed on the power of creating groups for stigmatized persons and their relatives. Indeed, people live within a dynamic world of group entities, and multiple social identities including spousal and familial. While attention has been paid to the diffusion of stigmas to loved ones, less has been paid to the uplift of group entities for them. 相似文献
9.
10.